Baldwin Investment Management LLC trimmed its stake in shares of The Sherwin-Williams Company (NYSE:SHW – Free Report) by 2.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,507 shares of the specialty chemicals company’s stock after selling 30 shares during the period. Baldwin Investment Management LLC’s holdings in Sherwin-Williams were worth $575,000 at the end of the most recent reporting period.
Other hedge funds have also modified their holdings of the company. Nations Financial Group Inc. IA ADV lifted its position in Sherwin-Williams by 13.0% during the 3rd quarter. Nations Financial Group Inc. IA ADV now owns 1,818 shares of the specialty chemicals company’s stock valued at $694,000 after purchasing an additional 209 shares during the period. Tamar Securities LLC lifted its holdings in Sherwin-Williams by 3.4% in the third quarter. Tamar Securities LLC now owns 48,753 shares of the specialty chemicals company’s stock valued at $18,608,000 after buying an additional 1,604 shares during the period. Valeo Financial Advisors LLC boosted its stake in Sherwin-Williams by 7.9% in the second quarter. Valeo Financial Advisors LLC now owns 2,636 shares of the specialty chemicals company’s stock valued at $787,000 after acquiring an additional 193 shares during the last quarter. Swedbank AB grew its holdings in Sherwin-Williams by 4.2% during the 3rd quarter. Swedbank AB now owns 117,055 shares of the specialty chemicals company’s stock worth $44,676,000 after acquiring an additional 4,681 shares during the period. Finally, Transcend Capital Advisors LLC raised its position in shares of Sherwin-Williams by 24.1% during the 2nd quarter. Transcend Capital Advisors LLC now owns 7,805 shares of the specialty chemicals company’s stock valued at $2,329,000 after acquiring an additional 1,514 shares during the last quarter. 77.67% of the stock is owned by institutional investors.
Sherwin-Williams Stock Performance
Shares of SHW opened at $394.00 on Thursday. The stock has a market capitalization of $99.23 billion, a price-to-earnings ratio of 39.24, a PEG ratio of 3.22 and a beta of 1.17. The Sherwin-Williams Company has a 12 month low of $272.34 and a 12 month high of $400.42. The firm has a fifty day simple moving average of $378.27 and a 200 day simple moving average of $345.96. The company has a current ratio of 0.83, a quick ratio of 0.51 and a debt-to-equity ratio of 1.97.
Sherwin-Williams Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 15th will be given a dividend of $0.715 per share. This represents a $2.86 annualized dividend and a dividend yield of 0.73%. The ex-dividend date of this dividend is Friday, November 15th. Sherwin-Williams’s dividend payout ratio (DPR) is 28.49%.
Wall Street Analyst Weigh In
Several equities analysts have weighed in on SHW shares. JPMorgan Chase & Co. increased their target price on Sherwin-Williams from $360.00 to $370.00 and gave the company an “overweight” rating in a research note on Wednesday, October 23rd. Jefferies Financial Group boosted their price target on shares of Sherwin-Williams from $392.00 to $415.00 and gave the company a “buy” rating in a report on Monday, August 26th. Robert W. Baird upped their price objective on shares of Sherwin-Williams from $350.00 to $360.00 and gave the company a “neutral” rating in a research report on Wednesday, October 23rd. Evercore ISI lifted their target price on Sherwin-Williams from $400.00 to $420.00 and gave the stock an “outperform” rating in a report on Thursday, November 7th. Finally, Morgan Stanley increased their price target on Sherwin-Williams from $375.00 to $450.00 and gave the stock an “overweight” rating in a report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $396.47.
Get Our Latest Analysis on Sherwin-Williams
Insider Transactions at Sherwin-Williams
In other Sherwin-Williams news, SVP Mary L. Garceau sold 15,770 shares of the business’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $397.92, for a total transaction of $6,275,198.40. Following the transaction, the senior vice president now owns 29,205 shares of the company’s stock, valued at $11,621,253.60. The trade was a 35.06 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Gregory P. Sofish sold 2,565 shares of the company’s stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $378.63, for a total value of $971,185.95. Following the completion of the sale, the senior vice president now owns 6,329 shares in the company, valued at $2,396,349.27. This represents a 28.84 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 32,855 shares of company stock worth $12,572,756 in the last 90 days. Corporate insiders own 0.60% of the company’s stock.
Sherwin-Williams Profile
The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.
Further Reading
- Five stocks we like better than Sherwin-Williams
- How to Calculate Return on Investment (ROI)
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Consumer Staples Stocks, Explained
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- The Significance of Brokerage Rankings in Stock Selection
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding SHW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Sherwin-Williams Company (NYSE:SHW – Free Report).
Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.